142 related articles for article (PubMed ID: 10818603)
1. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.
Lo YM; Leung SF; Chan LY; Lo KW; Zhang J; Chan AT; Lee JC; Hjelm NM; Johnson PJ; Huang DP
Ann N Y Acad Sci; 2000 Apr; 906():99-101. PubMed ID: 10818603
[No Abstract] [Full Text] [Related]
2. Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma.
Lit LC; Chan KC; Leung SF; Lei KI; Chan LY; Chow KC; Chan AT; Lo YM
Clin Chem; 2004 Oct; 50(10):1842-5. PubMed ID: 15319320
[No Abstract] [Full Text] [Related]
3. Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma.
Chan KC; Chan AT; Leung SF; Pang JC; Wang AY; Tong JH; To KF; Chan LY; Tam LL; Chung NY; Zhang J; Lo KW; Huang DP; Lo YM
Clin Chem; 2005 Nov; 51(11):2192-5. PubMed ID: 16244302
[No Abstract] [Full Text] [Related]
4. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.
Vo JH; Nei WL; Hu M; Phyo WM; Wang F; Fong KW; Tan T; Soong YL; Cheah SL; Sommat K; Low H; Ling B; Ng J; Tan WL; Chan KS; Oon L; Ying JY; Tan MH
Sci Rep; 2016 Dec; 6(1):13. PubMed ID: 28442757
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
9. Impact of plasma Epstein-Barr virus-DNA and tumor volume on prognosis of locally advanced nasopharyngeal carcinoma.
Chen M; Yin L; Wu J; Gu JJ; Jiang XS; Wang DJ; Zong D; Guo C; Zhu HF; Wu JF; He X; Guo WJ
Biomed Res Int; 2015; 2015():617949. PubMed ID: 25802858
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
[TBL] [Abstract][Full Text] [Related]
11. A novel application of plasma and cerebrospinal fluid level of epstein barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma. A case report.
Ma AT; Ma BB; Teo PM; Chan AT
Oncology; 2008; 74(1-2):119-22. PubMed ID: 18547967
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
13. Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Shen T; Tang LQ; Luo DH; Chen QY; Li PJ; Mai DM; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mo HY; Mai HQ
PLoS One; 2015; 10(4):e0122756. PubMed ID: 25853677
[TBL] [Abstract][Full Text] [Related]
14. Circulating DNA analysis: protocols and clinical applications using TaqMan assays.
Chan KC; Lo YM
Methods Mol Med; 2004; 97():217-36. PubMed ID: 15064496
[No Abstract] [Full Text] [Related]
15. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
16. Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer.
Cabezas-Camarero S; Pérez-Alfayate R; Puebla F; Cabrera-Martín MN; Pérez-Segura P
Oral Oncol; 2020 Apr; 103():104527. PubMed ID: 31866218
[No Abstract] [Full Text] [Related]
17. Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.
Kim KY; Le QT; Yom SS; Pinsky BA; Bratman SV; Ng RH; El Mubarak HS; Chan KC; Sander M; Conley BA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376165
[TBL] [Abstract][Full Text] [Related]
18. Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.
Chen WH; Tang LQ; Zhang L; Chen QY; Guo SS; Liu LT; Fan W; Zhang X; Guo L; Zhao C; Cao KJ; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Oncotarget; 2015 Nov; 6(35):38296-307. PubMed ID: 26512922
[TBL] [Abstract][Full Text] [Related]
19. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma.
Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL
Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906
[TBL] [Abstract][Full Text] [Related]
20. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?
Wong LP; Lai KT; Tsui E; Kwong KH; Tsang RH; Ma ES
Int J Cancer; 2005 Nov; 117(3):515-6. PubMed ID: 15906350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
